(Date:11/24/2009)...,, AUSTIN,Texas,Nov.24/PRNewswire/--NIP,Inc....up["RCG"],oneofthenation,sleadingexecutivecompensa...,CaliforniawithadditionalofficesinLosAngeles,Milwa...yWilliamMacDonald,arenownedexpertintheexecutiveben...uisitionofRCGwhichalreadyhassignificantmarketprese...
(Date:11/24/2009)...,, WHEATON,Ill.,Nov.24/PRNewswire-USNewswire...calGroup,hasbeennamedtherecipientoftheJamesBradyAw...iation(BIA)ofIllinoisduringtheirannualconferenceon...Dr.Escobarwasgiventheawardinrecognitionofhisexpert...juries,hiscompassionatetreatmentandexceptionalcare...
(Date:11/24/2009)...,, ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Ce...ississippiDivisionofMedicaidhasselectedCenteneason...heMississippiCoordinatedAccessNetwork(MississippiC...eneficiaries.CenteneisworkingwiththeDivisiontoexec...ersthroughoutthestate,asMagnoliaHealthPlan(Magnoli...
(Date:11/24/2009)... In-hospital death rates didn,t differ greatly bet... , TUESDAY, Nov. 24 (HealthDay News) -- Do...essarily produce the best results for patients? Ma...ractice makes perfect" when it comes to artery-ope...,000 patients finds low- and high-volume hospitals...
(Date:11/24/2009)... With Plavix as an example, study finds no added u... (HealthDay News) -- Direct-to-consumer drug ads m...to a new study that examined sales of the widely u...he analysis of data from 1999 to 2005 for 27 state...dvertising for clopidogrel did not increase people...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Advertising to Consumers May Raise Drug Prices 2... in Eastern Washington, SPOKANE, Wash., Jan. 15 ...tablishing a larger presence in the Spokane commun...40 people, including several,who are already emplo...e and we want to expand our operations in Eastern ...
...dia, and Marketing Benefit All Babies, WHITE PLAI...on pregnancy and baby health, expectant moms --,in...ed. Now the March of,Dimes makes it easier than ev...ble," said Dr. Jennifer L. Howse, President,of the...
...armaceutical Care,Management Association (PCMA) is...analysis released by the Congressional Budget Offi...sweeping antitrust exemptions for,independent phar...aid,the Federal Employees Health Benefits (FEHB) p...
... American Academy of,Ophthalmology expresses its s...earch on angiogenesis inhibitors sparked major adv...llnesses that involve excessive or,abnormal angiog...tive vice president for,the Academy. "Because of h...
... cancer gene,s newly discovered role in repairing ... a mutated copy of the gene are at increased risk ... The discovery also could lead to more effective t... it was discovered in 1994, BRCA1 and its role in ...
...h Expected Recurring Revenue Growth ...ch Impacts Fourth Quarter Revenue and Order ...Conference Call Today at 6 p.m. ET, ST. LOUIS, Ja..., and the delay in FDA approval of,this device for...
Other Medicine News:Health News:Washington Dental Service Opens Larger Spokane Office 2Health News:March of Dimes Offers New Resources for Pregnancy and Baby Health 2Health News:March of Dimes Offers New Resources for Pregnancy and Baby Health 3Health News:American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher 2Health News:New pathway provides more clues about BRCA1 role in breast cancer 2Health News:Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook 2Health News:Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook 3Health News:Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook 4(Date:11/24/2009)...ewswire-FirstCall/--IPCTheHospitalistCompany,Inc.(...ngrouppracticecompany,announcedtodaythatPhilipVaid...talist asoneofthe2009TopTenHospitalistsinthenation...e. ,, Dr.Vaidyanhasbeenapracticingphysicianform...almedicineatSt.Mary,sHealthCenterinSt.Louis,Missou...
(Date:11/24/2009)...Newswire/--VisageImaging®,Inc.,awhollyownedsu...gVisage®7,thecompany,snewgenerationdiagnostic...ogicSocietyofNorthAmerica(RSNA),November29toDecemb...ewlevelsofversatilityandperformancetoradiologists,...ns.TheVisage7UniversalViewerisasinglethinclientbas...
(Date:11/24/2009)...all/--KeryxBiopharmaceuticals,Inc.(Nasdaq: KERX )t...tiveOfficer,isscheduledtopresentatthePiperJaffray2...y. ,, Mr.Bentsur,spresentationwillbewebcastlive...blefromtheInvestorInformationpageoftheCompany,sWeb...onofthewebcastwillbeavailablefollowingtheconclusio...
Breaking Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X 2Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Business Leaders Support Free Choice Amendment to Senate Health Care Bill 57828 1Business Leaders Support Free Choice Amendment to Senate Health Care Bill 57828 2Elaine Alquist Willie Brown and Kim Belshe Convene Purple Ribbon Panel Task Force on Alzheimers 57826 1Elaine Alquist Willie Brown and Kim Belshe Convene Purple Ribbon Panel Task Force on Alzheimers 57826 2CEO and Founder of Project Lifesaver International Gene Saunders Selected to Receive Two Awards From Local Community 57824 1CEO and Founder of Project Lifesaver International Gene Saunders Selected to Receive Two Awards From Local Community 57824 2...(BUSINESS WIRE)--Apr 14, 2007 - In a late-breaker,...opean Association,for the Study of the Liver (EASL... interim analysis of the PROVE 1 clinical trial,w... therapy with,the investigational hepatitis C prot...tion with pegylated interferon (peg-IFN) and,ribav...
...s Prompted Phase 2 Study Now Underway at Nine,Cent.../ -- Ceregene,Inc., a biopharmaceutical company, ...ase 1 clinical trial of CERE-120, a gene,therapy p...on,s,disease, demonstrating a 36 percent (p<0.001)...ter administration, as measured,by the Unified Par...
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 2Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 3Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 4Paufique Suturing Forceps
O'Gawa Straight Suture-Fixation Forceps - 0.12 mm
Storz Suturing Forceps
Manhattan Eye and Ear Suturing Forceps
Medicine Products: